Integrating Buprenorphine Treatment Into Infectious Disease Settings

Open this course Estimated time to complete activity: 1 hour Audience: Providers
Credits Available: AMAAAPAANCCASWBACPECPH UAN #JA4008162-9999-20-2435-H01-P
Activity Release Date: October 28, 2020 Expiration Date: October 27, 2021

This module will describe: the epidemiology of opioid use disorder (OUD) and its impact on infectious disease epidemics in the United States, the use of medication treatment for OUD, and considerations for the management of infectious disease and OUD treatment.

Learning Objectives

  • Relate the epidemiology of opioid use disorder (OUD) and impact on infectious disease epidemics
  • Describe the use of medication treatment for OUD (MOUD) for treatment of OUD and importantly the use of buprenorphine
  • Discuss the considerations for the management of OUD and infectious disease treatment
  • Review the NASEM recommendations published January 2020 to address barriers to integration of infectious disease and OUD prevention and treatment services

Note:

Jointly provided by Postgraduate Institute for Medicine and HealthHIV